Search - tctmd.com

Displaying 121 - 140 of 2106

Sort: Relevancy | Date

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Another Win for PREVENT, This Time in Older Adults

Yael L. Maxwell

May 06, 2025

News Daily News

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Michael O'Riordan

May 02, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

Caitlin E. Cox

April 18, 2025

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

L.A. McKeown

April 14, 2025

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Caitlin E. Cox

April 14, 2025

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Daily News

AHA Tackles Need for Increased CV Prevention in Emerging Adults

Yael L. Maxwell

April 09, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Advertisement

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Another Win for PREVENT, This Time in Older Adults

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Black Adults Face CV Mortality Beyond Their Predicted Risk

AHA Statement Zeroes In On Sleep Health

Cardiotoxicity Rare With Common GI Chemotherapy

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Weekend Warriors Also See Mortality Benefits With Exercise

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

AHA Tackles Need for Increased CV Prevention in Emerging Adults

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

TCTMD’s Top 10 Most Popular Stories for March 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content